Countries South Korea
Everest Medicines' NEFECON® Gains Full Approval in South Korea for IgA Nephropathy Treatment
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing an...
November 19, 2024 | News
SK Biopharmaceuticals Partners with KIRAMS to Advance Radiopharmaceutical Cancer Therapies Using Actinium-225
SK Biopharmaceuticals, Korea Institute of Radiological and Medical Sciences collaborate on discovering and developing radiopharmaceutical drug candidates...
November 19, 2024 | News
South Korea’s Celltrion Acquires iQone Healthcare Switzerland to Boost Direct Commercialization of Biosimilars in Europe
Celltrion announces acquisition of iQone Healthcare Switzerland, accelerating direct commercialization of its biosimilars in the European region T...
November 18, 2024 | News
DX&VX Selected for South Korea's ARPA-H Project to Pioneer Room-Temperature mRNA Vaccine Storage
Pioneering Korea's ARPA-H Project: Focused on mRNA Vaccine Room-Temperature Storage and Extra-Long-Term Preservation Creating a Platform for Prolonged R...
November 04, 2024 | News
South Korean Neurophet Partners with LADO to Launch Brain PET Analysis Software in China, Establishes Joint Venture
Neurophet enters into a strategic agreement with LADO to distribute Neurophet SCALE PET Improves the efficiency of market entry with expertise of medica...
October 31, 2024 | News
Avance Clinical Bolsters Asia-Pacific Presence with Strategic Partnerships in South Korea
Avance Clinical, a leading full-service global Contract Research Organization (CRO), has announced the signing of three pivotal Memorandums of Understandin...
October 30, 2024 | News
GC Biopharma and Novelty Nobility Join Forces to Develop New Antibody Therapy for Geographic Atrophy in Age-Related Macular Degeneration
GC Biopharma announced that it has signed an agreement with Novelty Nobility, a biotech company specializing in the development of antibody-based therapeut...
October 29, 2024 | News
South Korea’s Qurient Launches Phase 1 Clinical Trial for Adrixetinib in AML Following FDA IND Clearance
Qurient has announced the commencement of a clinical trial for adrixetinib (formerly named Q702), following the clearance of its investigational new drug (...
October 25, 2024 | News
Lunit AI Cuts Radiologist Workload by 50% While Predicting Cancer Risk Up to Six Years in Advance, New Studies Show
Two new studies show Lunit INSIGHT MMG cuts radiologist workload by 50% in a double reading environment while maintaining or improving screening qua...
October 24, 2024 | News
SK bioscience Gains Approval for SKYCellflu in Indonesia, Expanding Global Reach for Cell-Cultured Influenza Vaccines
This approval paves the way for exports to the world's fourth most populous country. SK bioscience aims to continue to grow as a global vaccine brand be...
October 23, 2024 | News
Thermo Fisher Concludes Successful Bioprocess World Tour 2024 in APJ, Reigniting Industry Momentum Post-COVID
Thermo Fisher Scientific is proud to announce the successful conclusion of its highly anticipated Bioprocess World Tour 2024 in the Asia-Pacific and Japan ...
October 23, 2024 | News
Angelini Pharma Secures Global and Asia Licensing Option for Brain Health Compound CV-01 in Partnership with Cureverse
The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-011, a clinical Phase 1 investigational novel...
October 23, 2024 | News
Samsung Biologics Inks $1.24 Billion Manufacturing Agreement with Leading Asia Pharma
Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), announced a contract manufacturing deal with an As...
October 23, 2024 | News
South Korea Approves XPOVIO® for Third Indication in Multiple Myeloma Treatment
This approval for XPOVIO® for the treatment of patients with multiple myeloma (MM) marks the third approved indication of the drug in South...
October 21, 2024 | News
Most Read
- Why Cell Therapy Systems Are Going Automatic: A New Era of Manufacturing
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
